InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,884.53
(
0.94%
)
Post# of 252428
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: ghmm post# 208049

Monday, 01/16/2017 9:49:34 PM

Monday, January 16, 2017 9:49:34 PM

Post# of 252428
JAKs/alopecia -

yes I've heard other JAK's for Alopecia but I don't know where any of the programs stand.

Found this fairly recent article talking about JAKs (ruxolitinib/tofacitinib) in trials for alopecia: http://www.medscape.com/viewarticle/869388 . Early results seem promising. Doesn't appear to me that INCY and PFE are directly involved in these studies so perhaps ACRS is one of the few (only?) companies that is directly involved in pursuing JAKs for alopecia for now.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up